Gliflozins — sodium–glucose cotransporter 2 inhibitors — lower blood glucose and glycated hemoglobin in patients with type 2 diabetes without causing hypoglycemia. The agents also improve cardiac function in patients who have heart failure with or without type 2 diabetes and improve renal function, with few adverse effects.
PDF的下载单位、IP信息已删除
(2025-6-4)
Kao
Criminology34
GingerF
cnspower
wueeee
王雪
时尚梦易
无极微光
jfkyt
Copyright
OK
潇洒的惋清
结实的小蚂蚁
可耐的鑫磊
学术文献互助
YifanWang
pluto
MchemG
初景
遇上就这样吧
皖公网安备34019202002308
